atherosclerotic lesions_Ldlr<tm1Her>/Ldlr<tm1Her>

http://metadb.riken.jp/0005338B6129S7Ldlrtm1HerLdlrtm1HerLdlrtm1HerLdlrtm1Her

atherosclerotic lesions_Ldlr<tm1Her>/Ldlr<tm1Her>

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• low density lipoprotein receptor
  http://metadb.riken.jp/db/mgi_rdf/MGI:96765

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Ldlr<tm1Her>/Ldlr<tm1Her>

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Ldlr<tm1Her>

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• B6.129S7-Ldlr<tm1Her>

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• atherosclerotic lesions
  http://purl.obolibrary.org/obo/MP_0005338

文献

http://purl.org/net/cito/citesAsAuthority

• H. Sjöland, et.al., Atherosclerosis progression in LDL receptor-deficient and apolipoprotein E-deficient mice is independent of genetic alterations in plasminogen activator inhibitor-1., Arteriosclerosis, thrombosis, and vascular biology, 2000, 20
  http://rdf.ncbi.nlm.nih.gov/pubmed/10712412
• Ara M. Aslanian, et.al., Transient role for CD1d-restricted natural killer T cells in the formation of atherosclerotic lesions., Arteriosclerosis, thrombosis, and vascular biology, 2005, 25
  http://rdf.ncbi.nlm.nih.gov/pubmed/15591216